Lv51
948 积分 2026-08-27 加入
Diet-refractory NASH in an elderly woman
5分钟前
待确认
Treatment of Metabolic (Dysfunction)-Associated Fatty Liver Disease: Evidence from Randomized Controlled Trials—A Short Review
18分钟前
已完结
Misoprostol for non-alcoholic steatohepatitis: a randomised control trial
25分钟前
已完结
A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD
29分钟前
已完结
Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction–associated steatotic liver disease
1小时前
已完结
Screening for liver fibrosis - sequential non-invasive testing works best
1小时前
求助中
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
2小时前
已完结
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
2小时前
已完结
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
3小时前
已完结
皖公网安备34019202002308
